Ping An Biomedical Co., Ltd. filed a Form F-1 registration statement for an initial public offering on 2024-10-04. It has amended it 7 times. It filed its final prospectus on 2025-07-21, at a public offering price of $6.00 per share. Each fact below is quoted from the filing named with it.
What the filings say
Listing
Our Ordinary Shares are listed on the Nasdaq Stock Market under the symbol “PASW.” On February 12, 2026, the last reported sales price of our Ordinary Shares was $0.2185 per share.From the F-1 filed 2026-02-13
Shares offered
We are offering 2,500,000 Shares of MIHL, representing 12.2% of the Shares following the completion of this offering, assuming the underwriters do not exercise the over -allotment option.From the 424B4 filed 2025-07-21
Offering price
The initial public offering price is $6.0 per Share.From the 424B4 filed 2025-07-21
Use of proceeds
We intend to use the net proceeds from this offering as follows:From the 424B4 filed 2025-07-21
Net loss or income
Although we recorded net income of RMB237,704 (US$32,920) for the six months ended March 31, 2024, we cannot assure you that we will be able to continue to generate net income in the future.From the F-1/A filed 2024-11-04
Withdrawal
Pursuant to Rule 477 under the Securities Act, the Company hereby requests that the Commission consent to the withdrawal of the Registration Statement, effective as of the date hereof.From the RW filed 2024-10-04
Timeline
| Filed | What it is | Filing |
|---|---|---|
| 2024-10-04 | Request to withdraw a registration (Form F-1) | RW |
| 2024-10-04 | Registration statement filed (foreign issuer) | F-1 |
| 2024-10-23 | Registration statement amended (foreign issuer) | F-1/A |
| 2024-11-04 | Registration statement amended (foreign issuer) | F-1/A |
| 2025-01-24 | Registration statement amended (foreign issuer) | F-1/A |
| 2025-03-17 | Registration statement amended (foreign issuer) | F-1/A |
| 2025-03-25 | Registration statement amended (foreign issuer) | F-1/A |
| 2025-04-14 | Registration statement amended (foreign issuer) | F-1/A |
| 2025-06-26 | Registration statement amended (foreign issuer) | F-1/A |
| 2025-07-21 | Final prospectus filed: the offering is priced | 424B4 |
| 2026-02-13 | Registration statement filed (foreign issuer) | F-1 |
Tools for this story
Each opens in a new tab, filled in for Ping An Biomedical Co., Ltd.. With no account yet, you sign up free and land on the result.
Where this comes from
A company that wants to sell shares to the public in the United States files a registration statement with the SEC: Form S-1 for a US company, Form F-1 for a foreign one. It amends that statement as the figures and terms are filled in, usually adding the expected price range shortly before the offering. Once the offering is priced it files its final prospectus under Rule 424(b)(4). A company that decides not to go ahead can ask for the registration statement to be withdrawn on Form RW.
Every row on this page is one of those filings, linked to the filing itself. The facts are the company's own sentences, quoted from the filing named beside each one and never reworded; where no filing states a fact in a sentence that can be read exactly, this page leaves it out. A filing is the company's statement of its plans and its figures, not a verification of them, and nothing here is investment advice.